For the quarter ending 2026-03-28, CALX had -$88,485K decrease in cash & cash equivalents over the period. $6,516K in free cash flow.
| Cash Flow | 2026-03-28 | 2025-12-31 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Total revenue | 279,984 | 272,449 | 265,437 | - |
| Adjusted cost of revenue | 119,793 | 114,375 | 112,292 | - |
| Adjusted sales and marketing operating expenses | 56,837 | 59,609 | 54,099 | - |
| Adjusted research and development operating expenses | 48,757 | 47,133 | 41,091 | - |
| Adjusted general and administrative operating expenses | 21,276 | 20,045 | 19,550 | - |
| Other segment items | 20,605 | 22,012 | 21,000 | - |
| Interest income and other expenses, net | 2,516 | 23,277 | -4,676 | - |
| Income Tax Expense Benefit | 4,022 | 25,340 | -2,929 | - |
| Income taxes | -6,077 | - | 10,099 | - |
| Net income (loss) | 11,210 | 7,212 | 15,658 | -4,986 |
| Stock-based compensation | 20,605 | 21,953 | 20,619 | 45,357 |
| Depreciation and amortization | 4,376 | 4,400 | 4,697 | 8,613 |
| Deferred income taxes | 1,274 | 4,133 | 10,063 | -1,285 |
| Net accretion of available-for-sale securities | 435 | 696 | 864 | 2,137 |
| Accounts receivable, net | 17,405 | 11,902 | 24,389 | -16,245 |
| Inventory | 20,889 | 25,755 | -2,540 | 7,795 |
| Prepaid expenses and other assets | -804 | -6,000 | 2,455 | -13,752 |
| Accounts payable | 26,243 | 21,580 | -2,355 | 2,284 |
| Accrued liabilities | -10,298 | 8,953 | 4,451 | -10,387 |
| Deferred revenue | 232 | 6,345 | -1,954 | -1,748 |
| Other long-term liabilities | -1,083 | 3,823 | 6,303 | -1,320 |
| Net cash provided by operating activities | 14,634 | 46,046 | 32,314 | 56,593 |
| Purchases of property and equipment | 8,118 | 5,765 | 5,625 | 8,045 |
| Purchases of marketable securities | 10,038 | 53,903 | 71,820 | 95,116 |
| Sales of marketable securities | 24,621 | 16,780 | 0 | 11,362 |
| Maturities of marketable securities | 41,388 | 37,409 | 50,671 | 117,679 |
| Net cash provided by investing activities | 47,853 | -5,479 | -26,774 | 25,880 |
| Proceeds from common stock issuances related to employee benefit plans | 19,999 | 24,375 | 16,624 | 24,197 |
| Repurchases of common stock | 170,869 | 16,620 | 3,479 | 73,531 |
| Payments related to financing arrangements | - | 0 | - | - |
| Net cash used in financing activities | -150,870 | 7,755 | 13,145 | -49,334 |
| Effect of exchange rate changes on cash and cash equivalents | -102 | -248 | -211 | 237 |
| Net decrease in cash and cash equivalents | -88,485 | 48,074 | 18,474 | 33,376 |
| Cash and cash equivalents at beginning of period | 143,086 | 95,012 | 43,162 | - |
| Cash and cash equivalents at end of period | 54,601 | 143,086 | 95,012 | - |
CALIX, INC (CALX)
CALIX, INC (CALX)